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Abstract
Natural or fertility awareness-based methods (FABMs) help users monitor, interpret, and
systematically chart female biological markers. FABMs are used as family planning methods
and sometimes as reproductive health monitoring methods. The American College of
Obstetricians and Gynecologists (ACOG) encourages medical professionals to use female
reproductive cycle patterns, ‘the female fifth-vital sign’, as a means of improving the diagnosis
and treatment of reproductive health diseases, disorders, and conditions. Patients need to have
accurate knowledge of healthy and unhealthy cycle patterns. The general public does not have a
sufficient level of fertility health knowledge. This study examined whether females that are
interested and not interested in using FABMs for health monitoring and family planning differ in
their mean reproductive health knowledge scores (average of six knowledge questions), and
whether certain demographic characteristics or having been prescribed the hormonal birth
control pill for reproductive health abnormalities predict female interest in using FABMs for
health monitoring or family planning. A 52-item survey was administered to a national sample
of 665 reproductive age women in March 2018. An independent samples t-test and two binary
regression models were run using the Statistical Package for Social Sciences software (SPSS).
Of the total 665 female participants 279 (41.9%) females reported not being interested in using
FABMs for family planning and 386 (58%) females are interested. Females who were not
interested in using FABMs for health monitoring (n=352) had a statistically significantly (p<.05)
higher mean knowledge scores (73.6%) compared with the knowledge scores (68.8%) of females
who were interested (n=237). Similarly, females who were not interested in using FABMs for
family planning (n=279) had a statistically significantly (p<.05) higher mean knowledge scores
(75.1%) compared with the knowledge scores (69%) of females (n= 386) who were interested.

No demographic characteristics nor having been prescribed the hormonal birth control pill for
reproductive health abnormalities significantly predicted female interest in using FABMs for
health monitoring or family planning. These findings suggest that interest in FABMs for family
planning or health monitoring is not isolated to a specific demographic of reproductive age
women.
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Introduction
Evidence suggests that one in 10 women worldwide are affected by endometriosis which
can lead to infertility (Research priorities in endometriosis published, 2009). In fact, data from
the 2002 National Survey of Family Growth (NSFG) conducted by the Centers for Disease
Control and Prevention (CDC) estimated 7.3 million American women aged 15–44 years had
impaired fecundity (i.e., experienced difficulties conceiving or bringing a pregnancy to term
during their lifetime), with 11.5% of them receiving infertility services (Chandra, Martinez,
Mosher, Abma, & Jones, 2005). In addition, some women of reproductive age suffer from a
variety of chronic and acute reproductive health problems, including: infertility, endometriosis,
polycystic ovarian disease, premenstrual syndrome, uterine fibroids, heavy or painful periods,
and hypothalamic amenorrhea (Boyle, de Groot, Andralojc, & Parnell, 2018; Common
Reproductive Health Concerns for Women, 2018; Nnoaham et al., 2011; Vigil, Ceric, Cortés, &
Klaus, 2006).
The United States’ public health initiative, Healthy People 2020, identified the reception
of reproductive health services as a leading health indicator for reproductive and sexual health
attainment (U.S. Department of Health and Human Services (USDHHS), 2010). The American
College of Obstetricians and Gynecologists (ACOG) encourages patients, as early as
adolescents, and primary care clinicians to discuss reproductive health patterns at every patient
visit in an effort to improve the diagnosis and treatment of reproductive health problems
(American College of Obstetricians and Gynecologists, 2015). However, research suggests that
40% of American women do not know about or understand their fertility cycles, and are
therefore ill-equipped to monitor their reproductive health patterns (ACOG, 2015; Lundsberg,
Pal, Gariepy, Xu, Chu, & Illuzzi, 2014). In addition, clinicians continue to prescribe the
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hormonal birth control pill as the first-line of treatment for symptoms related to a variety of
reproductive health problems (Legro et al., 2013). Prescribing hormonal birth control contradicts
ACOG's recommendation to have females monitor their cycle patterns and receive treatments
that correct underlying reproductive health problems, not simply manage symptoms (ACOG,
2015).
On the other hand, natural or fertility awareness-based methods (FABMs) are
comprehensive reproductive health methods that enable women to monitor, manage, and
maintain their reproductive health as well as plan their family (Boyle et al., 2018; Hilgers, 2004;
Institute for Reproductive Health, n.d.; Smoley, & Robinson, 2012; World Health Organization,
1995). FABMs are evidence based methods that have no side effects, and are free of hormonal
therapies, injections, and implants (Manhart, Duane, Lind, Sinai, & Golden-Tevald, 2013;
Urrutia et al., 2018). Certain FABM educational programs provide direct instruction to users
providing them with necessary knowledge about biological markers, as well as have the skills to
follow evidence based protocols for tracking and charting reproductive health patterns (Arevalo,
Jennings, Nikula, & Sinai, 2004; Arevalo, Jennings, & Sinai, 2002; Bhargava, Bhatia,
Ramachandran, Rohatgi, & Sinha, 1996; Fehring, Schneider, Raviele, Rodriguez, & Pruszynski,
2013; Frank-Herrmann et al., 2007; Howard, & Stanford, 1999; Peterson et al., 2000). Research
suggests that charting with a FABM produces an effective diagnostic tool for identifying and
treating underlying causes of reproductive health problems, including infertility (Boyle et al.,
2018; Hilgers, 2004; Vigil et al., 2006). In addition, FABMs are effective and comprehensive
family planning methods, helping couples to avoid and achieve pregnancy (Boyle et al., 2018;
Manhart et al., 2013; Urrutia et al., 2018). Therefore, women can potentially use FABMs to
access the full scope of reproductive health services: family planning, health monitoring, and
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knowledge about healthy menstrual cycle patterns (Boyle et al., 2018; Hilgers, T.W. 2004; Vigil
et al., 2006). However, we do not yet know if females are interested in using FABMs for health
monitoring or if females are still interested in using them for family planning.
Family Planning
Beginning at the onset of puberty, healthy males are always fertile, constantly producing
sperm (Hilgers, 2002). Females are mostly infertile during their reproductive years (Duane,
2019; Hilgers, 2002). A female’s reproductive years range from 12 to 51 years of age (ACOG,
2015). Over the course of the average 21-35 day cycle a female ovulates once, typically
releasing one egg, with an average fertile window of 6 days (Briden, 2017; Wilcox, Weinberg &
Baird, 1995). Given the physiological nature of the male and female reproductive systems an
inclusive discussion of family planning must address the full scope of a couples’ reproductive
capacity to either avoid or achieve pregnancy.
Avoiding Pregnancy
There are 6.1 million pregnancies each year in the United States; 45% of those are
unplanned (Finer & Zolna, 2016). Unplanned pregnancy rates are higher for Black and Hispanic
women, 18-24 years old, partners that cohabit, those with an income below the poverty line, and
those who have not completed high school (Finer & Zolna, 2016). An inability to access family
planning services also contributes to unplanned pregnancy rates (Chandra et al., 2005; ChandraMouli, McCarraher, Philips, Williamson, & Hainsworth, 2014). Barriers to access include cost,
service office hours and locations, and a lack of knowledge of available resources and services in
communities (Guttmacher Institute, 2014b). Unplanned pregnancy is associated with negative
maternal and infant health outcomes and an increase in cost to the general public (Child Trends,
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2007; D’Angelo, Gilbert, Rochat, Santelli, & Herold, 2004; Guttmacher Institute, 2015; Tsui,
McDonald-Mosley, & Burke, 2010).
Healthy men and women have about a 30% chance of achieving a pregnancy resulting
from random acts of sexual intercourse during a single female reproductive cycle, with an 82%
chance of conception over the course of 12-months (Wilcox et al., 1995; Zinaman, Clegg,
Brown, O’Connor, & Selevan, 1996). The most effective method to avoid unplanned pregnancy
is to abstain from all acts of sexual intercourse (American Academy of Pediatrics, 2016; “How
effective are abstinence and outercourse?” 2019; “Sexual Risk Behaviors,” 2018). 1.5% of
sexually active men and women practice periodic abstinence to avoid pregnancy (NCHS
National Survey of Family Growth, 2018). Most sexually active men and women use
pharmaceutical birth control, sterilization procedures, or barrier methods to avoid pregnancy
(NCHS National Survey of Family Growth, 2018). Pharmaceutical birth control or barrier
methods mitigate the chances of an unplanned pregnancy while remaining sexually active
(Reproductive Health: Contraception, 2018). Nearly all sexually active females report using a
pharmaceutical birth control or barrier method during their lifetime (Daniels, Mosher & Jones,
2013). In the United States the most common methods of birth control are female sterilization
(18.6%), the oral birth control pill (12.6%), long-acting reversible contraceptives (LARCs)
(10.3%), and male condoms (8.7%). Typical use method effectiveness rates for avoiding
pregnancy range from 99% (hormonal implant-LARC) to 87% (male condom) (Reproductive
Health: Contraception, 2018). Despite high effectiveness rates, 47% of women who have used at
least one method of birth control will discontinue use due to dissatisfaction with the method
(Daniels et al., 2013). The most commonly cited reason for discontinuation of hormonal
methods, such as the birth control pill (64% discontinuation rate) and some LARCs, is side
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effects (Daniels et al., 2013). Therefore, females that are able to access family planning services
may not find a method with which they are satisfied. In addition, a variety of factors influence a
woman’s choice of birth control including: birth control options available, cost of method, sexual
partnership characteristics, how frequently they engage in sexual intercourse, religious
affiliation, pregnancy and method related experiences (having had an unplanned pregnancy while
using a birth control pill in the past), and attitudes toward use of the method (Daniels et al.,
2013; Guttmacher Institute, 2014a; Wiesman, Lehman, Legro, Velott, & Chuang, 2015).
Therefore, helping women and couples find, access, and effectively use methods to avoid
pregnancy that are free of side-effects, are cost effective, and address other influencing factors
will help couples achieve planned pregnancies and avoid unplanned pregnancy. Eventually
leading to improved health, social, and economic outcomes for parents and children (Cheng,
Schwarz, Douglas, & Horon, 2008; Child Trends, 2007; D’Angelo, Gilbert, Rochat, Santelli, &
Herold, 2004; Finer, & Zolna, 2016; Guttmacher Institute, 2015; Kost, Landry, & Darroch, 1998;
Tsui et al., 2010).
Achieving Pregnancy
Conception requires the presence of healthy male sperm, a healthy female egg, and the
presence of high quality female cervical fluid (Hilgers, 2002; Odeblad, 1994). When a healthy
man and woman engage in random acts of sexual intercourse they have a 30 percent chance of
conceiving a child during each reproductive cycle (Wilcox et al., 1995; Zinaman et al., 1996).
The majority of men and women report that parenthood is a goal for their future (Hammarberg et
al., 2017a; Prior, Lew, Hammarberg, & Johnson, 2018; Sorensen et al., 2016). On average men
and women desire or expect to have two or more children during their reproductive life (National
Center for Health Statistics, 2016; Prior et al., 2018). Health factors that predict an increased or
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decreased likelihood of a couple achieving a pregnancy include: age, weight (overweight or
underweight), diet, alcohol consumption, stress, level of caffeine intake, smoking, presence of
reproductive disease, and sexual health history (Centers for Disease Control and Prevention,
2014). Research suggests the general public is not knowledgeable about these factors and
research suggests that more people are starting families later in life (Bunting et al., 2013;
Hammarberg, Collins, Holden, Young, & McLachlan, 2017a; Hammarberg et al., 2017b;
Houston, Abraham, Huang, & D'Angelo, 2006; Lundsberg et al., 2014; Peterson et al., 2012).
Additionally, male and female fertility experiences in the United States differ when considering
factors such as: level of educational level, household income in relation to the federal poverty
line, and Hispanic origin and race (National Center for Health Statistics, 2018b).
Reproductive Health
Reproductive health refers to the diseases, disorders, and conditions that affect the
functioning of the male or female reproductive system at every stage of life (Reproductive
Health, 2018). Examples of female reproductive diseases are endometriosis, polycystic ovarian
disease (PCOS), uterine fibroids, gynecologic cancers (cervical, uterine, ovarian), sexually
transmitted infections (STI), premenstrual syndrome (PMS), and ovarian dysfunction (Common
Reproductive Health Concerns for Women, 2018; Houston, Abraham, Huang, & D’Angelo,
2006; Vigil et al., 2006). Reproductive diseases, disorders, and conditions can result in impaired
fecundity, the inability to conceive or carry a pregnancy to term and have a live birth (Common
Reproductive Health Concerns for Women, 2018). At least 6% women are unable to achieve a
pregnancy after engaging in sexual intercourse for 12 months (Boyle et al., 2018). While almost
15% of women will experience a miscarriage during the first trimester of pregnancy (Cohain,
Buxbaum, & Mankuta, 2017).
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The average female enters menarche, onset of menstruation, around the age of 12 or 13
(ACOG, 2015). However, a female begins the process of reproductive maturation as an embryo
(Vigil, Lyon, Flores, Rioseco, & Serrano, 2017). Female reproductive functioning begins in the
brain with communication between the hypothalamus and pituitary gland, the HPO axis (Popat,
Prodanov, Calis, & Nelson, 2009). Evidence suggests that it takes years for the HPO axis to
mature (Mansfield & Emans, 1989). Establishing a healthy HPO axis and regular cycle patterns
is associated with an adolescent’s body weight, diet, gene structure, the presence of synthetic or
artificial hormones, as well as environmental factors (Briden, 2017; Damstra, 2002; Mansfield &
Emans, 1989; Popat et al., 2009; Vandenberg et al., 2012; Vigil et al., 2017; World Health
Organization, 2011). During this time, it is normal for adolescent females to experience irregular
cycle patterns (Mansfield & Emans, 1989). When cycle irregularity is not attributed to a
maturing HPO axis, but an other anatomic or endocrine problem, underlying reproductive
diseases, disorders, and conditions should be medically investigated (Mansfield & Emans, 1984;
Popat et al., 2009; Vigil et al., 2017).
As much as 75% of adolescent females, ages 10-19 years old, report problems with
menstruation as their primary reason for doctor’s visits (Slap, 2003). In December 2015, ACOG,
endorsed by The American Academy of Pediatrics, published a committee opinion encouraging
physicians to inquire about their adolescent patients’ menstrual pattern at every appointment
(ACOG, 2015). Tracking cycle patterns during adolescence, dubbed tracking the female ‘fifth
vital sign’, can help clinicians identify and treat a variety of female reproductive problems
(ACOG, 2015). This suggestion is negated when physicians use the hormonal birth control pill
as the first-line of treatment for reproductive problems (Legro et al., 2013). In fact, one in three
women are reportedly taking the birth control pill to regulate their menstrual cycle (as cited in
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Lambert, 2015). However, when females track their natural menstrual cycle patterns using
cooperative and corrective treatments underlying causes of symptoms can be addressed (ACOG,
2015; Brown, 2011; Mansfield & Emans, 1984; Popat et al., 2008; Vigil et al., 2006). Early
diagnosis and treatment of various reproductive problems may prevent infertility and impaired
fecundity in the later stages of a woman's reproductive years (Centers for Disease Control and
Prevention, 2014). Currently, an accurate diagnosis of certain reproductive disorders can take up
to 11 years, and can be associated with an inept production of natural female hormones (Briden,
2017; Ding et al., 2017; Goodman et al., 2015; Rogers et al., 2009; Sinaii, Cleary, Ballweg,
Nieman, & Stratton, 2002). Research suggests there are many short and long-term health
benefits associated with the natural production and fluctuation of ovarian hormones, estradiol
and progesterone (Briden, 2017; Manuvais-Jarvis, Clegg, & Hevener, 2013; Mecangi et al.,
2014; Mohammed et al., 2015; ; Mong et al., 2011; Prior, 2014; Sathi, Kalyan, Hitchcock,
Pudek, & Prior, 2013; Schussler et al., 2008; Smith et al., 2014). Therefore, earlier diagnosis and
treatment of reproductive diseases may allow females to experience the health benefits
associated with natural progesterone and estrogen (Briden, 2017; Manuvais-Jarvis et al., 2013;
Mecangi et al., 2014; Mohammed et al., 2015; ; Mong et al., 2011; Prior, 2014; Sathi et al., 2013;
Schussler et al., 2008; Smith et al., 2014)
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Female Reproductive Health Knowledge
Reproductive cycle phases are distinct from one another, yet work systematically to
orchestrate a functioning reproductive cycle (Briden, 2017; Hilgers, 2002; Vigil et al., 2017).
The fluctuation of hormones, beginning in the female brain and endocrine system, is essential for
the overall health and function of the reproductive cycle (Popat et al., 2009). The follicular
phase begins with the first day of menstruation and continues until ovulation (Briden, 2017;
Fehring, Schneider, & Raviele, 2006). Ovulation happens once each cycle; however, the process
of follicular maturation leading to ovulation takes 100 days (Briden, 2017). A healthy ovulatory
event precedes a healthy luteal phase, 9-17 days in length, and a healthy menses (Briden, 2017;
Fehring, Schneider & Raviele, 2006; Hilgers, 2002). Sufficient knowledge about each phase of
the cycle, not just ovulation or menstruation, constitutes adequate reproductive health
knowledge. The ability to identify healthy and unhealthy cycle patterns is an important skill for
females seeking care for reproductive cycle problems (ACOG, 2015)
Findings from previous research suggests the general public, practicing medical
professionals, and medical trainees, are lacking knowledge of fertility health topics in different
ways (Kudesia, Chernyak, & McAvey, 2017; Lampic, Svanberg, Karlstrom, & Tyden, 2006;
Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018; Slap, 2003; Sørensen et al., 2016;
Stern, Larsson, Kristiansson, & Tyden, 2013). These studies primarily explored the amount of
knowledge participants had about ovulation, family planning intentions, assisted reproductive
technologies, physiological and life-style factors impacting the ability to achieve pregnancy, and
menstruation (Kudesia et al., 2017; Lampic et al., 2006; Lundsberg et al., 2014; Peterson et al.,
2012; Prior et al., 2018; Slap, 2003; Sorensen et al., 2016; Stern et al., 2013). While other
studies examined participant knowledge, attitudes, and beliefs regarding ovulation and
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menstruation they failed to investigate participants’ knowledge of healthy reproductive cycle
patterns (e.g., “How long is a healthy menses?”, or “What is a healthy cycle length, in days?”)
(Houston et al., 2006; Lundsberg et al., 2014; Slap, 2003). Knowledge and understanding of
healthy reproductive cycle patterns can help patients identify abnormalities and seek a diagnosis
or receive treatment for a reproductive disease, disorder, or condition (ACOG, 2015; Boyle et al.,
2018; Hilgers, 2004; Popat et al., 2009; Vigil et al., 2006).
Having knowledge about healthy reproductive cycle patterns is important for the general
and medical populations (ACOG, 2015). Research suggests that males and females want to
know and understand their fertility health (Hampton, Mazza, & Newton, 2013; Lundsberg et al.,
2014). However, one study found that 40% of women aged 18-40 were not knowledgeable
about when ovulation occurs or the characteristics of cervical fluid secretions that are observable
during that cycle phase (Lundsberg et al., 2014). The same study also reported that 40% of
women were unaware that females do not produce new eggs during their reproductive life
(Lundsberg et al., 2014). Although, Lundsberg et al., (2014) found that the majority of women
(70%) believe that females should consider their reproductive health well before they are ready
to conceive.
Fertility Awareness Based Methods (FABMs)
Natural or fertility awareness-based methods (FABMs) refer to family planning methods
that allow users to identify various external biological markers that are indicative of their fertility
health (Odeblad, 1994; Pallone & Bergus, 2009; Pyper, 1997; Smoley & Robinson, 2012).
External biological markers can include: basal body temperature, urinary metabolites, and
cervical fluid secretions (Odeblad, 1994; Su et al., 2017). All FABMs are free of artificial
hormonal therapies, injections, implants, and have no side effects (Manhart et al., 2013; Urrutia
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et al., 2018). Additionally, some FABMs can help users achieve pregnancy and monitor their
reproductive health (from menarche to menopause) (Boyle et al., 2018; Hilgers 2004; Vigil et al.,
2006). Thus, FABMs can be used to meet a wide range of female reproductive health needs:
family planning (achieving or avoiding) and monitoring reproductive health. Despite the utility
of modern FABMs, and the research suggesting women are interested in using FABMs for
family planning, it is estimated that only 1% to 3% of reproductive age females in the United
States are currently using a FABM (as cited in Pallone & Bergus, 2009; Stanford, Lemaire, &
Thurman, 1998). These estimates only reflect rates of FABM use for family planning. There is
no information about the percent of females that are using a FABM for health monitoring.
FABMs are family planning options suggested for use by the World Health Organization
(WHO), American College of Obstetricians and Gynecologists (ACOG), Centers for Disease
Control and Prevention (CDC) and most recently by the Food and Drug Administration (FDA)
(ACOG, 2019; “Contraception,” 2018; “FDA Allows Marketing of First,” 2018; World Health
Organization, 1988).
Five Primary Types
FABMs are often classified based on their underlying mechanism(s) of action (Smoley &
Robinson, 2012). The five primary FABM categories are calendar methods, lactation methods,
cervical fluid methods, sympto-thermal methods, or sympto-hormonal methods (Fehring et al.,
2013; Smoley & Robinson, 2012). Some FABMs can be used to help couples achieve
pregnancy; however, they are commonly discussed as methods to avoid pregnancy (Boyle, 2017;
Hilgers, 2004; Manhart et al., 2013; Urrutia et al, 2018). Effectiveness rates for avoiding
pregnancy and a brief explanation of specific FABMs will now be explored in more detail.
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Calendar and Lactation Methods.
The Standard Days Method® (SDM), is an effective, inexpensive and modern calendarbased family planning method (Arevalo et al., 2002). Developed by Georgetown University's
Institute for Reproductive Health (IRH), SDM helps women avoid pregnancy by using a colorcoded string of beads, CycleBeads®, to track when they are menstruating and when they are most
likely to be fertile (Sinai, Jennings & Arévalo, 2004). Users do not monitor external biological
markers. This modern calendar based method is for women with regular length cycles, ranging
from 26-32 days which encompasses 80% of female cycles (Arevalo et al., 2002; Sinai, Jennings
& Arévalo, 2004). With perfect use, 5% of women will get pregnant after one year (Arevalo et
al., 2002). With typical use, 12% of women will experience an unplanned pregnancy after one
year (Arevalo et al., 2002).
The Lactational Amenorrhea Method (LAM) is based on the scientific understanding of
the natural suppressive effect that exclusive breastfeeding has on female ovulation for up to six
months postpartum (Labbock et al., 1997). During breastfeeding, the nipple stimulation that
results from infant suckling interferes with hormone communication between the brain and ovary
which suppresses ovulation (Chao, 1987). The LAM protocol is highly effective at helping
postpartum mothers avoid pregnancy if they have not had a return of menses, are exclusively and
frequently breastfeeding (daytime and nighttime), and their infant is less than 6 months old
(Labbock et al., 1997). Postpartum mothers make no observations of biological markers when
using LAM. The perfect use rate for avoiding pregnant is 99% and the typical use rate is 98%
(Labbock et al., 1997).
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Cervical Fluid Methods.
Three FABM mucus methods will be discussed here, The Billings Ovulation Method
(Billings Method), The Creighton Model FertilityCare System (Creighton Model), and the Two
Day Method. Cervical fluid method users identify their ovulatory phase by making external
observations of fluid secretions present at the vulva (Fehring, 2002; Odeblad, 1994). Daily
tracking of cervical fluid informs users about their reproductive cycle phase (fertile or infertile)
and health (Fehring, 2002; Hilgers, 2004; Odeblad, 1994; Vigil et al., 2017). Protocols have
been developed for Billings and Creighton Model users with various cycle patterns (irregular,
regular, anovulatory, post-partum, etc…). Perfect use pregnancy rates among the
aforementioned methods range from 0.1 to 3.5 per 100 women years (Hilgers & Stanford, 1998;
Urrutia et al., 2018). Use effective pregnancy rates range from 3.2 to 33.6 per 100 women years
(Hilgers & Stanford, 1998; Urrutia et al., 2018).
Sympto-Thermal and Sympto-Hormonal Methods.
Once a female ovulates the rise in progesterone has a thermogenic effect on her basal
body temperature raising it by 0.5-1.0-degree Fahrenheit for the duration of the luteal phase (Su
et al., 2017). Tracking basal body temperature is a retrospective indicator that ovulation has
occurred. Method users take their basal body temperature at the same time every day and track
cervical fluid secretions, count calendar days, or feel for the positioning of the cervix (Smoley &
Robinson, 2012; Urrutia et al., 2018). Typical use pregnancy probability rates range from 1.8-33
unplanned pregnancies per 100 women years, with perfect use pregnancy rates ranging from 0.412 unplanned pregnancies per 100 women years (Urrutia et al., 2018).
Approximately 35-44 hours prior to ovulation a female will experience a rise in her
luteinizing hormone level (LH level) with a noticeable surge 10-12 hours preceding ovulation
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(Cahill, Wardle, Harlow, & Hull, 1998; Hoff, Quigley, & Yen, 1983; Su et al., 2017). Users of a
sympto-hormonal method track daily urinary LH levels using a digital hormone reader, or a
digital reader and cervical fluid observations (Fehring, Schneider, Raviele, & Barron, 2007).
Typical use pregnancy probability rates range from 2-25.6 unplanned pregnancies per 100
women years, with perfect use pregnancy rates ranging from 0-12.1 unplanned pregnancies per
100 women years (Urrutia, 2018). Some researchers propose that the use of a sympto-hormonal
method is not always the most efficacious application of the underlying physiological science
(Qublan et al.,, 2006; Su et al., 2017).
Family Planning
Females and their partners use FABMs to inform their choice of when they will engage in
sexual intercourse based on their family planning goals (Manhart et al., 2013; Urrutia et al,
2018). Evidence suggests that typical use failure rates for avoiding pregnancy are comparable
between some FABMs and pharmaceutical or barrier methods (“Contraception,” 2018). Typical
use pregnancy rates for methods such as the hormonal shot, oral birth control pill, the patch,
male or female condoms, and spermicides range from 4% to 21% (“Contraception,” 2018).
Typical use pregnancy rates per 100 woman years for FABMs range from 2-23% (Urrutia et al.,
2018). FABMs can help users identify days when they are fertile in order to target sexual
intercourse when they want to achieve a pregnancy (Wilcox et al., 1995). A couple’s time to
pregnancy (TTP) is the number of female reproductive cycles that pass where acts of sexual
intercourse take place and pregnancy is not achieved. TTP can be lessened when sexual
intercourse occurs on days associated with a high probability of conception taking place
(Stanford & Dunson, 2007).
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Avoiding Pregnancy.
Based on recent evidence found from a systematic review of the literature, perfect use
pregnancy probability rates for FABMs range from 0-12.1, and typical use pregnancy rates range
from 0.4 to 33.6 per 100 woman-years (Urrutia et al., 2018). Efficacious use of FABMs to avoid
pregnancy stipulates that users abstain from sexual intercourse during the fertile window
(Howard & Stanford, 1999; Manhart et al., 2013). Furthermore, users experience greater degrees
of effectiveness when avoiding pregnancy when they learn method protocols from trained
educators (Arevalo et al., 2004; Arevalo et al., 2002; Bhargava et al., 1996; Hilgers & Stanford,
1998; Howard, & Stanford, 1999; Fehring et al., 2013; Frank-Herrmann et al., 2007; Peterson et
al., 2000; Sinai, Jennings & Arévalo, 2004). The range of reported typical use and perfect use
effectiveness rates reflects 1) different study designs 2) participant demographic characteristics
3) the study’s timeline or approach used for determining participant’s pregnancy intentionality 4)
study participants documented the use of barrier methods during the fertile window and 5) the
mechanism(s) of action on which the method is based (Manhart et al., 2013; Urrutia et al., 2018).
Further discussion of these topics is not pertinent to the focus of this paper; however, these issues
are addressed in greater detail by scholars in published literature (Frank-Herrmann et al., 2007;
Stanford & Dunson, 2007). While FABMs are commonly referenced as methods used to avoid
pregnancy, some FABMs have evidence supporting their utility in helping reproductively healthy
and unhealthy partners achieve pregnancy (Boyle et al., 2018; Gnoth, Godehardt, Godehardt,
Frank-Herrmann, & Freundl, 2003; Stanford, & Dunson, 2007; Tham, Schliep, & Stanford,
2012).
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Achieving Pregnancy.
According to Wilcox, Weinberg, and Baird (1995), the majority of pregnancies are
achieved when sexual intercourse takes place within a six-day window, ending with the day of
ovulation. In fact, evidence suggests that the optimal time for a couple to engage in sexual
intercourse and have the highest likelihood of a single act resulting in a pregnancy is two days
prior to ovulation (Tiplady, Jones, Campbell, Johnson, & Ledger, 2013). Accurate identification
and interpretation of cervical fluid secretions is an effective approach for females seeking to
identify their six-day window of fertility (Odeblad, 1997). However, research suggests the
general public does not have this basic fertility knowledge (Kudesia et al., 2017; Lundsberg et
al., 2014). Most evidence based FABMs require that females and their partners receive direct
and explicit instruction about biological markers, observational routines, and method specific
tracking protocols from a trained FABM educator in order to effectively learn method protocols
(Arevalo et al., 2004; Bhargava et al., 1996; Fehring et al., 2013; Hilgers & Stanford, 1998;
Labbok et al., 1997; Sinai et al., 2004). These educational phases address a variety of fertility
knowledge topics (Arevalo et al., 2004; Bhargava et al., 1996; Fehring et al., 2013; Hilgers &
Stanford, 1998; Labbok et al., 1997; Sinai et al., 2004). Furthermore, the knowledge and
understanding gained from working with FABM educators can equip method users with the
necessary skills to track their cycle health, and to avoid or achieve pregnancy (Boyle et al., 2018;
Hilgers, 2004; Vigil et al., 2017; Vigil et al., 2006).
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Female Reproductive Health
FABMs can be used by females throughout their reproductive life (Arevalo et al., 2004;
Arevalo et al., 2002; Bhargava et al., 1996; Briden, 2018; Chao, 1987; Fehring et al., 2007;
Golden-Tevald, 2013; Hilgers, 2004; Tham et al., 2012; Vigil et al., 2006). Cervical fluid
methods work for females with varying cycle patterns: irregular, regular, anovulatory,
premenopausal, postpartum, and breastfeeding (Bhargava et al., 1996; Chao, 1987; Fehring,
Barron, & Schneider, 2005; Hilgers, 2004). Evidence suggests that charting each phase of the
female reproductive cycle using cervical fluid methods can address underlying reproductive
diseases, disorders, and conditions (Boyle et al., 2018; Hilgers, 2004; Vigil et al., 2017; Vigil et
al., 2006). Charting is a diagnostic tool that allows trained clinicians to assess a patient’s
reproductive health and use cooperative medical and surgical treatments to address and attempt
to correct underlying causes of reproductive abnormalities (Tham et al., 2012; Stanford, Parnell,
& Boyle et al., 2008; Vigil et al., 2017). Furthermore, ACOG recommends females begin to
track and chart their cycle patterns during adolescents (ACOG, 2015). Charting during
adolescence may help address the underlying causes of menstrual disorders that affect 75% of
young female patients (ACOG, 2015; Slap, 2003).
Restorative Reproductive Medicine (RRM) refers to reproductive medicine where by
medical and surgical techniques are used to cooperatively restore reproductive health and ovarian
function (Boyle et al., 2018). Clinicians practicing RRM use patient charting as a diagnostic tool
to assess and treat underlying causes of reproductive diseases that can lead to impaired fecundity
(Boyle et al., 2018; Common Reproductive Health Concerns for Women, 2018; Hilgers, 2004;
Stanford et al., 2008; Tham et al., 2012; Vigil et al., 2006). Medical practices that establish
healthy reproductive cycle patterns by restoring ovulatory function and the fluctuation of ovarian
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hormones can lead to improved female health, pregnancy rates, and live birth outcomes (ACOG,
2015; Boyle et al., 2017; Briden, 2017; Schüssler et al., 2008; HIlgers 2004; Popat et al., 2009;
Prior, 2014; Vigil et al., 2017).
In fact, one study examined where RRM treatments were used to correct underlying
causes of impaired fecundity in couples who had not received IVF treatments and had struggled
for an average of 5.6 years to have a child reported live birth rates of 61.5% (Stanford et al.,
2008). More recent evidence suggests that for females of advanced maternal age (35-38 years
old) and undergone multiple failed attempts of IVF treatment, they had a successful live birth
rate of 37.5% with RRM (Boyle et al., 2018). The same study reported that women over 40 who
had undergone multiple failed attempts of IVF treatment, had a 27.4% live birth rate (Boyle et
al., 2018). Compared with IVF, charting the female cycle with a FABM in conjunction with
restorative reproductive healthcare results in more favorable outcomes for mothers and infants
with potential economic savings to the health care system (Boyle et al., 2008; Centers for
Disease Control and Prevention, 2018). However, only 3-6% of medical professionals are
knowledge about FABMs and there applications to women’s reproductive health (Stanford,
Thurman & Lemaire, 1999).
Current Study
In 1998 and 2006 respectively, two separate cross-sectional survey studies reported
female interest in using natural family planning (NFP) to avoid or achieve pregnancy in isolated
populations in Missouri and Arizona (Leonard, Chavira, Coonrod, Hart, & Bay, 2006; Stanford
et al., 1998). These two studies suggested that a percentage of females are interested in using
NFP methods for family planning (Leonard et al., 2006; Stanford et al., 1998). In 1998, 22.5%
of female respondents expressed an interest in using a NFP method to avoid a pregnancy, and
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37.4% were interested in using NFP to achieve a pregnancy (Stanford et al., 1998). In 2006,
61% of females said they would be ‘likely’ or ‘very likely’ to use a NFP method to avoid a
pregnancy, and 50% said they would use NFP to try to achieve a pregnancy (Leonard et al.,
2006). Leonard et al., (2006) and Stanford et al., (1998) used different survey instruments to
measure females’ interest in FABMs in two different populations of females.
These previously conducted surveys (1998 and 2006) are the most recent data available
describing female’s interest in using NFP, and suffered from limitations. For example, the 1998
study collected data from 484 potentially fertile women via mail-based surveys by randomly
selected driver’s license renewal records in Missouri, between 1991 and 1992 (Stanford et al.,
1998). The 2006 study included 357 women, 82% of which were Hispanic, and collected survey
responses from women of reproductive age (18 to 44) waiting for a medical appointment at one
hospital system in Phoenix, AZ (Leonard et al., 2006). Studies limited by geographic location
and social indicators (e.g., having driver’s license) limit the conclusions that can be made
(Leonard et al., 2006; Stanford et al., 1998). In light of recent research suggesting the utility of
FABMs in women’s healthcare it is appropriate to ask females if they are interested in using
FABMs for family planning and health monitoring (Boyle et al., 2018; Hilgers, 2004; Vigil et al.,
2017).
Using data collected from a national survey of reproductive age women, 18-55 years old
in spring 2018, this study examined whether females were interested or not interested in using
FABMS for family planning or health monitoring. Previous studies found that pregnancy
history, previous use of FABMs, future intention to have children and other factors predicted
females interest in using FABMs for family planning (Leonard et al., 2006; Stanford et al.,
1998). This study explored whether having been prescribed the hormonal birth control pill for
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reproductive health abnormalities or certain demographic characteristics (age, race/ethnicity,
marital/relationship status, religious affiliation, level of education, annual income, and health
insurance status) or predicted females interest in using FABMs for health monitoring or family
planning. In contrast to previous research on FABM interest, this study also examined the
difference in reproductive health knowledge between females that reported being interested and
not interested in using FABMs for health monitoring and family planning. Exploring knowledge
score differences between interested and not interested females was predicted to be helpful the
future planning of FABM public health programming. Thus, female interest in FABMs was
examined by asking two research questions, 1) Is there a difference in the mean reproductive
health knowledge score between females that are interested in using FABMs for health
monitoring and family planning and females that are not interested in using FABMs for health
monitoring and family planning? and 2) Does having been prescribed the hormonal birth control
pill for reproductive health abnormalities and certain demographic characteristics predict
females’ interest in using FABMs for health monitoring or family planning?
Methods
Participants & Procedures
A national sample of 665 women of reproductive age, 18-55, completed an online survey
between March 4, 2018 and March 11, 2018. The survey was administered by Qualtrics Online
Survey Company. Qualtrics elicited incentivized participation from their national pool of
participants who met specific eligibility criteria. Eligibility criteria included being biologically
female, between the ages of 18-55, be potentially fertile (i.e., having not had a hysterectomy,
oophorectomy, or been sterilized, and having not yet entered menopause), and be currently or
planning to engage in vaginal-penile sexual intercourse with male partners only or both male and
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female partners. Participants who indicated that they did not plan to ever engage in vaginalpenile sexual intercourse or only engage in sexual intercourse with female partners were not
prompted to complete the final section of the survey about family planning. Participants read a
consent clause prior to completing the survey that stated by beginning the survey they were
consenting to participate. All survey responses were anonymous and participation in the study
was voluntary. This study received approval from the Institutional Review Board (IRB) at the
University of Arkansas prior to collecting data (see Appendix C).
In total, about 77% (n=512) of the participant were between the ages of 18 and 37 years
old (M= 31, SD= 8.44) All participants identified as female (n=665). Almost 73% (n=487) of the
participants identified as being White/Caucasian. Nearly 85% (n=561) of female participants
were either living with a partner (n=119), married (n=262), or single (n=180). Half of the
participants, 51% (n=340), identified as Christian. About 75% (n=503) of participants
completed some college, have an associates, bachelors, masters, doctorate, medical doctor or
other professional graduate degree. Exactly 17% (n=113) of participants reported an annual
household income of less than $15,000 and 19% (n=129) of participants reported an annual
household income of more than $75,000. Lastly, 85% (n=557) of the participants responded,
“Yes,” when asked whether or not they had health insurance (see Appendix A, Table 1 for more
demographic details).
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Measures
The survey consisted of 52 questions divided into three sections. At the beginning of
each section, participants were given a brief reading prompt explaining the aim of the survey
section and included definitions of terminology found in the survey. Each of the three sections
within the survey included a participant screening question that read, “This question is to make
sure you are truly reading and answering the questions. If you are reading and answering
questions please choose, ‘I am reading and answering questions,’ as your answer choice.” The
question format was close-ended, open-ended, and there was one matrix question. Survey
questions were created as well as adapted from previous studies and addressed: 1) personal
knowledge about basic reproductive cycle health (e.g., length of days, knowledge of observable
signs of fertility and infertility) 2) interest in use of FABMs for family planning (i.e., avoiding
and achieving pregnancy when desired) 3) interest in use of FABMs to monitor health (for
themselves and/or a family member – i.e. a daughter, niece, or young woman in their care) and
4) prior family planning methods that had been used, duration of use, and reason(s) for
use/discontinuation (Stanford et al., 1998; Leonard et al., 2006; see Appendix B for the complete
survey).
Demographics. Participants were asked to answer questions including their age,
race/ethnicity, sexual identity, marital/relationship status, religious affiliation, educational
attainment level, current household income, health insurance status, and reproductive health
history. Reproductive health history questions, “How many times have you been pregnant?”,
“How many pregnancies have you had that resulted in the birth of a living child? (total number
of children born alive)”, as well as a screening question asking participants to identify whether or
not they have already gone through menopause or have had a hysterectomy. Reproductive health
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history questions were taken from a previous survey evaluating female interest in FABMs for
family planning (Stanford et al., 1998).
Knowledge of female menstrual cycle. Participants answered seven knowledge-based
questions about the female menstrual cycle. These questions were created based on previous
research examining the general populations current fertility knowledge level as reported by
Lundsberg et al., (2014), and in collaboration with professionals working in the field of
reproductive healthcare. Various question formats were used. For example, some questions
included “select all that apply” options (e.g., “What is considered a healthy menstrual cycle
length?” ), multiple choice (e.g., “How many days in each menstrual cycle does a female
ovulate?”, options included one, two, three, a woman can ovulate once a day for more than three
days each cycle, and I don’t know), and True/False (e.g., “It is NOT necessary for a female to
ovulate regularly (approximately once a month) in order to be considered healthy as long as she
is regularly bleeding.”). True/False questions also included an “I don’t know” option.
Participants were asked to identify where or from whom they learned information about healthy
menstrual cycle patterns. Knowledge question responses were scored as correct or incorrect.
Previous reproductive health experiences. Four survey questions inquired about
female’s previous or current use of hormonal birth control to address an underlying reproductive
health problem. Question formats included, “yes or no” (e.g., “Have you ever used or are you
currently using a birth control pill or other hormonal contraceptive method as a treatment for a
reproductive health problem such as: irregular cycles, painful periods, bad cramps, heavy
periods, or other.”), and multiple choice, (e.g., “If you have used, or are currently using, a birth
control pill or other hormonal contraceptives as a treatment for a reproductive health problem,
who prescribed the treatment?”, options included medical professional, self-prescribed,
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parent/family member, other). The third question prompted participants with an answer choice
option of “select all that apply” (e.g., “Select the reason you FIRST started using the birth
control pill or other hormonal contraceptives to treat a reproductive health problem?”). Lastly,
females were asked to report at what age they recalled starting to use birth control to treat a
health problem (e.g., “younger than 8 years old” to “after 50”). If participants responded, “no,”
to ever having received hormonal birth control to treat a reproductive health condition they were
automatically moved on to the next survey question.
Willingness to perform health behaviors. Participants were asked about their willingness
to perform health behaviors necessary to make observations of reproductive biological markers.
This included seven statements explaining various health behavior practices required of FABM
users. A Likert type scale was used to measure participant willingness to perform the stated
health behavior. An example statement is “Wiping with toilet tissue before and after EVERY
bathroom visit looking for cervical fluid on a tissue.” Participants selected one answer choice
(e.g., “I am NOT willing, I might be willing if I knew more, I am willing, I am already doing
this”).
Use of family planning methods. Participants were first asked to identify, “choose all that
apply,” important characteristics they consider when choosing a family planning method (e.g.,
reliability, effectiveness, ease of use, acceptability of method to a partner, potential side effects,
cost, or other). Next, participants were asked to indicate which methods of family planning they
were currently using or had previously used. For prior use, participants were asked to report, via
open ended textbox, the reason for discontinuation of the method. This section also asked three
closed-ended and one open-ended question created by the researcher in collaboration with
colleagues about use of fertility/period tracking apps, including which apps, and why they were
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using them (e.g., “Do you use a period tracking OR fertility tracking app?”, “Which app or apps
did you use?”, “What is your purpose(s) for using a period tracking or fertility tracking app?”,
“What is your commitment to the period tracking or fertility tracking app?”)
Familiarity with and interest in using FABMs. Participants were asked a single multiplechoice question to indicate when they would consider using FABMs (e.g., “When would you
consider using a FABM?”). Answer choices included, “For monitoring my health,” “For family
planning (achieving pregnancy only),” “For family planning (avoiding pregnancy only),” “For
family planning (achieving and avoiding pregnancy),” “For family planning (achieving
pregnancy only) and health monitoring,” “For family planning (avoiding pregnancy only) and
health monitoring,” “For family planning (achieving and avoiding pregnancy) and health
monitoring,” and “I would not use FABMs for monitoring my health or for family planning,
even if I was confident in reliability, it was easy to learn and acceptable to my partner.”
Additional questions were adapted from previous studies measuring female interest in FABM
use for family planning (Stanford et al., 1998; Leonard et al., 2006). Additionally closed-ended
vs. open ended and multiple choice questions were generated to measure the extent to which
participants were familiar with FABMs, (e.g., “Please check below ALL Fertility Awareness
Based Methods (FABMs) that you are at all FAMILIAR with even if you have never used an
FABM”), prior use of FABMs to monitor reproductive health (e.g., “Please check below
ALL Fertility Awareness Based Methods (FABMs) that you have EVER used TO MONITOR
YOUR REPRODUCTIVE/MENSTRUAL CYCLE HEALTH ONLY. ***This does NOT
include using FABMs for the purposes of trying to achieve or avoid pregnancy.***”), with a
follow-up open-ended question prompting the participant to elaborate on having used the
‘calendar rhythm method,’ (e.g., “You marked that you have used the Calendar Rhythm Method
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to monitor your reproductive/menstrual cycle health. Please explain what the Calendar Rhythm
Method is.”). The remaining questions inquired about prior participant use of FABMs for family
planning (avoiding or achieving pregnancy), a “select all that apply” option choice was used for
all questions. If participants selected prior use of the Calendar Rhythm Method for family
planning they were not promoted to explain the Calendar Rhythm Method. Lastly, participants
were asked to “select all that apply” when identifying other females, they believed might be
interested in learning more about FABMs for family planning or health monitoring. Upon
completion of the survey participants were provided direct links to various FABM teaching
organizations if they wanted to learn more about a particular method.
Data Analysis
Statistical analysis was carried out using the Statistical Package for the Social Sciences
(SPSS). Prior to calculating the mean reproductive health knowledge score, one knowledge
question was eliminated (e.g., “True or False: It is not necessary for a female to ovulate regularly
in order to be considered healthy as long as she is regularly bleeding.”). This question was
removed because of conflicting findings in research that suggest ovulation is not essential for
health and findings that suggest it is essential for health (Guttmacher Institute, 2011; Vigil et al.,
2017). Thus, the mean knowledge score was calculated using the remaining six knowledge
questions. After this question was eliminated, frequency and percent rates were generated for 1)
the six reproductive health knowledge questions 2) prior or current use of hormonal birth control
to treat reproductive health problems and 3) when participants indicated they would consider
using FABMs.
Participant responses to the survey question, “When would you consider using a FABM?
was used to identify participants interested and not interested in using a FABM. Answer choices
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allowed for participants to choose one of the options that included family planning only, health
monitoring only, or a combination of both. For the purpose of the analyses, these responses were
recoded into two different variables, one for interest in using FABMs for family planning, and
the other for interest in using FABMs for health monitoring. To do this, any answer choice that
included use for family planning was coded as ‘yes’ for interest in FABMs for family planning.
Answer choices that indicated no interest in use for family planning, or use only for health
monitoring, were coded as ‘no’ for interest in FABMs for family planning. Similarly, any answer
choice that indicated interest in FABMs for health monitoring was recoded to reflect the
selection of an answer choice with health monitoring as ‘yes’ and the selection of an answer
choice without health monitoring as ‘no’.
Due to the distribution of categorical demographic variables, some variables were
dichotomized for the purpose of analyses. Demographic variables were dichotomized as follows:
1) race/ethnicity: white & non-white 2) relationship status: committed & non-committed 3)
highest level of academic achievement: some college and above & no college 4) insurance status:
insured & no insurance and 5) religiously affiliated and not affiliated. Given the homogeneous
makeup of the participant sample, all females, participants’ sex was not included in the analysis.
In addition, the independent and categorical variable, prior or current use of hormonal birth
control for reproductive health problems (e.g., “Have you ever used or are currently using a birth
control pill or other hormonal contraceptive method as a treatment for a reproductive health
problem, such as irregular cycles, painful periods, bad cramps, heavy periods, other…”) was recoded using ones to indicate ‘yes’ and zeros to indicate a ‘no’.
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Research question one.
Two independent samples t-tests were run to answer the first research question, “Is there
a difference between the mean knowledge scores of females who are interested or not interested
in using FABMs for family planning or health monitoring?” The hypothesis was, there was no
difference between the mean knowledge scores of females interested or not interested in FABMs
for family planning or health monitoring. Mean knowledge scores were calculated for each
group (interested and not interested) by averaging the number of correct responses to the six
knowledge questions. Participant responses were scored as correct or incorrect. The average
knowledge score for a participant that answered all six knowledge questions correctly was one.
The independent variable was the mean knowledge score. The dependent variables were female
interest in using FABMs for family planning or health monitoring.
Research question two.
Two binary logistic regression models were used to answer the second research question,
“Does having been prescribed the hormonal birth control pill for health problems and certain
demographic characteristics predict female interest in using FABMs for family planning or
health monitoring?” The null hypothesis was that no demographic characteristics or prior or
current use of hormonal birth control for a reproductive health problem would predict female
interest in using FABMs for family planning or health monitoring. The research hypothesis was
that one or more demographic variables would predict female interest in using FABMs for health
monitoring or family planning. A second hypothesis was that previous or current use of
hormonal birth control would positively predict female interest in using FABMs for health
monitoring but not family planning. Independent variables included the demographic
characteristics of the female participant population and prior or current use of hormonal birth
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control. Dependent variables were female interest in using FABMs for family planning or health
monitoring.
Results
Almost 75% (n = 493) of females indicated that they would consider using a FABM for
health monitoring or family planning, while 25% (n = 172) of participants would not use a
FABM for health monitoring or family planning (see Appendix A, Table 2). Of these women,
58% (n = 386) indicated they would consider using a FABM for family planning, and 42.8% (n =
285) would use a FABM for health monitoring. In contrast, 41.9% (n = 279) females would not
consider using a FABM for family planning, and 57.1% (n = 380) would not consider using a
FABM for health monitoring.
Research Question 1. Frequencies showed that 4.5% of females (n = 30) correctly
identified short, regular, and long cycle lengths as possible healthy menstrual cycle lengths (see
Appendix A, Table 3). The majority of females, 98.1%, correctly identified a healthy number of
days for a female to be menstruating (n = 652). When asked, “Can a female become pregnant
while on her menses?”, 68.5% of participants responded, “Yes,” (n = 456), 19.4% selected,
“No,” (n = 129), and 12% answered, “I don’t know,” (n = 80). A fourth of females, 25% (n =
166), did not correctly identify, “One,” as the correct number of days a female ovulates each
menstrual cycle. Of the 665 study participants, 59.5% (n = 396) chose, “True,” when responding
to the ‘True/False’ statement, “Females are able to get pregnant at ANY time in their menstrual
cycle.” Over 75%, (n= 532) of females indicated that females can identify when they are fertile
by identifying external biological markers.
Contrary to the hypothesized outcome, there was a significant difference (p<.05) in the
average reproductive health knowledge scores for females not interested in using FABMs for
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family planning (M= 0.75, SD= 0.23) or health monitoring (M= 0.73, SD= 0.23) and females
who were interested in using FABMs for family planning (M= 0.69, SD= 0.23) or health
monitoring (M= 0.68, SD= 0.23) (see Appendix A, Table 4). For both outcomes, independent
samples t-test results suggested those who were not interested in using FABMs had higher mean
knowledge scores.
Research Question 2. Two binary logistic regression tests were conducted to predict
interest in using FABMs for family planning (n = 386) and health monitoring (n=285). Predictor
variables included age, annual household income, and the dichotomized demographic variables:
race (white/non-white), religion (religiously affiliated/not religiously affiliated),
relationship/marital status (committed/non-committed), education (some college/no college), and
insurance status (insured/not insured). Prior or current use of hormonal birth control for
reproductive health was also added as an independent, categorical, predictor variable that was
dichotomized for both regression models (see Appendix A, Table 5).
The Hosmer and Lemeshow test was used to measure how well the data fit the statistical
models, where an alpha level greater than .05 indicates a good fit (Bertolini, D'Amico, Nardi,
Tinazzi, & Apolone, 2000). The data fit the two regression models for health monitoring (p=
0.704) and family planning (p = 0.475). No demographic variable, nor the use of hormonal birth
control for health problems, significantly predicted (p < .05) female interest in using FABMs for
health monitoring or family planning (see Appendix A, Table 6). Although, some variables did
show a marginal significance (p < .10). For example, a trend in the data suggests that as
previous or current use rates of hormonal birth control for reproductive health problems increase,
interest in using FABMs for health monitoring decreases (OR: 0.876, CI: 0.63-1.20). In addition,
as female age decreased interest in using FABMs for family planning increased (OR: 0.981, CI:
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0.962-1.00). Thus, these results conclude a failure to reject the null hypothesis. The pseudo R2,
Nagelkerke R2, did not suggest a significant relationship between the independent and dependent
variables, 0.021 (interest in health monitoring) and 0.028 (interest in family planning).
Discussion
The purpose of this study was to explore whether females were interested or not
interested in using FABMs for family planning and health monitoring in a national sample of
women of reproductive age. First, differences were examined in the mean reproductive health
knowledge scores for those participants indicating that they were and were not interested in using
FABMs. The results suggest that females with lower mean reproductive health knowledge
scores were more likely to be interested in using FABMs for health monitoring and for family
planning. Differences in knowledge scores for participants who were and were not interested in
using FABMs for family planning revealed, contrary to the hypothesis, those who were not
interested in using FABMs for family planning had higher knowledge scores than those who
were interested. Again, contrary to the hypothesis, those who were not interested in using
FABMs for health monitoring had significantly higher mean knowledge scores than those who
were interested. Perhaps females with more reproductive health knowledge are less interested in
using a FABM for family planning or health monitoring because they feel confident in their level
of fertility awareness and do not believe learning about a specific FABM is necessary. In
contrast, females with lower mean knowledge scores may be more interested in FABMs for
family planning and health monitoring because of a desire to learn more and fill the gaps in their
fertility awareness knowledge. Therefore, females who are interested in using FABMs for
family planning and health monitoring will benefit from the fertility awareness education they
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receive while learning to use a FABM from a trained educator (Arevalo et al., 2004; Fehring et
al., 2013; Hilgers & Stanford, 1998; World Health Organization, 1981).
Previous research examining reproductive knowledge related topics asked different
questions and used a different scoring system (Kudesia et al., 2017; Lampic et al., 2006;
Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018; Slap, 2003; Sorensen et al., 2016;
Stern et al., 2013). Thus, findings from this study are hard to compare with findings from most
other research measuring fertility health-related knowledge. That being said, the response
frequencies for the individual knowledge questions found in this study corroborate with ACOGs’
(2015) claim that females are not aware of what cycle patterns are healthy and unhealthy.
Results from this study suggest that current or previous use of hormonal birth control for
reproductive problems and demographic characteristics are not significant (p<.05) predictors of
female interest in using FABMs for health monitoring or family planning. Previous research by
Stanford and colleagues, (1998) did find that age (<30 years old) was a significant predictor of
female interest in using FABMs to achieve pregnancy (family planning). A similar trend was
found in this study suggests that as participant age decreased interest in using FABMs for health
monitoring (OR: 0.98, CI: 0.96-1.00) and family planning (OR: 0.981, CI: 0.96-1.00) increased
(see Appendix A, Table 6). Unlike this study, Leonard and colleagues, (2006) found that
educational attainment significantly predicted female interest in using FABMs to avoid
pregnancy (family planning). In contrast with Stanford and colleagues (1998) and Leonard and
colleagues (2006), this study explored the previous or current use of hormonal birth control for
health monitoring and demographic characteristics as predictor variables of female interest.
These previous studies examined whether pregnancy history, pregnancy intentions, previous use

32

of natural family planning (NFP) methods, or a select number of demographic characteristics
predicted female interest in the use of FABMs for family planning.
Surprisingly, the use of hormonal birth control did not predict interest in FABMs for
health monitoring. FABMs are side-effect free alternatives to hormonal methods currently used
to diagnose, manage, and treat reproductive health problems (Briden, 2017; Legro et al., 2013).
In light of the large percentage of females that report discontinuing hormonal birth control due to
side-effects, it was hypothesized that FABMs would be an interesting alternative for females
prescribed hormonal methods for health problems. Findings from this study suggest that this may
not be the case. In fact, marginally statistically significant (p < .10) trends in the data support the
opposite. Given that no demographic variable significantly predicted female interest in the use
of FABMs for health monitoring or family planning, FABM programs could be applicable and
may be of interest to a broad range of the population.
Limitations
Some limitations deserve to be highlighted. While the participant sample size (n= 665)
was drawn from a national participant pool it is not nationally representative. For example, 73%
of the participants were White/Caucasian. In addition, the knowledge questions used in this study
were created or adapted from other research. Therefore, this is not a previously validated
instrument to measure reproductive health knowledge. Such an instrument does not exist. Future
research may attempt to create a reliable measure to assess knowledge. While such surveys exist
to measure knowledge about fertility as it pertains to the ability to conceive, that was not the goal
of this study and therefore such instruments were not applicable. Furthermore, the survey is
quite lengthy, a total of 52 questions. Therefore, participant burnout is also a potential threat to
the validity and generalizability of findings.
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Future Research and Implications for Public Health
This study contributes to the literature on females’ interest in FABMs for family planning
and health monitoring in three ways, 1) promoting FABM use in clinical practice 2) suggesting
female interest in FABMs for health monitoring and 3) the need to improve reproductive and
fertility health literacy by way of FABM public health programs. First, results suggest that
women from a national sample, and of reproductive age, are interested in using FABMs for
family planning and health monitoring. This finding is perhaps most descriptive of the interest
of younger women. Further research is needed to explore physicians current knowledge about
these methods as well as exploring their beliefs and attitudes about FABMs and their intentions
to offer them in the clinical setting. Depending on those findings, research may need to examine
how clinicians can improve their medical knowledge about the science and application of
modern FABMs so that these methods can be offered to patients during family planning and
reproductive health appointments. Second, this was the first study to assess females' interest in
using FABMs for health monitoring, and we found that many are, indeed, interested in using
them for this purpose (42.8%). Studies investigating how to best promote FABM use for health
monitoring may help current and future FABM professionals more effectively market these
methods to reproductive age women. Given that female interest in FABMs does not translate
into the use of these methods, it may be helpful to explore factors that influence females’
intention to use FABMs (Mikolajczyk, Stanford, & Rauchfus, 2003). Ones’ intention to perform
a behavior is arguably the best predictor of behavior (Ajzen & Klobas, 2013). Therefore, future
research should explore the degree to which females’ attitudes, subjective norms, and perceived
behavioral control predict their intention to perform FABM related health behaviors (e.g.,
“Wiping before and after each bathroom visit to observe cervical fluid.”). Further, research
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exploring females’ beliefs and knowledge about FABMs and their applications for reproductive
health may provide insight about why more participants were interested in FABMs for family
planning over health monitoring. Third, findings from this study corroborate findings from
previous research as well as the recommendations from ACOG suggesting that public health
researchers need to consider how to best improve or develop programming and intervention
efforts that address reproductive health literacy in the general population (ACOG, 2015; Kudesia
et al., 2017; Lampic et al., 2006; Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018;
Slap, 2003; Sorensen et al., 2016; Stern et al., 2013). An increase in patients’ reproductive
health literacy is suggested as a way to hasten the identification and treatment of reproductive
diseases, disorders, and conditions in order to improve long term reproductive health outcomes
(ACOG, 2015). Certain FABM educational programs may be effective ways to address the
knowledge gap and equip females with the necessary skills to monitor their female ‘fifth vital
sign’. Further research is needed to explore how such programs should be structured, identify
the ideal setting for program implementation, and measure the short and long term outcomes
(knowledge, health, etc.) of these programs. Further research is needed to explore physicians
current knowledge about these methods as well as exploring their beliefs and attitudes about
FABMs and their intentions to offer them in the clinical setting. Finally, more research is needed
to examine why females with higher knowledge scores are less interested in using FABMs for
health monitoring and family planning.
Conclusion
Females are interested in using FABMs. The American College of Obstetricians and
Gynecologists (ACOG) suggests that females track their reproductive health patterns in order to
improve short and long-term health outcomes (ACOG, 2005). Findings from this study and
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others suggest women do not have a sufficient level of reproductive health knowledge in order to
monitor their cycle patterns (ACOG, 2015; Kudesia et al., 2017; Lampic et al., 2006; Lundsberg
et al., 2014). Further research is needed to explore whether females have the skills and intention
to perform health behaviors associated with monitoring their reproductive cycle patterns. In
addition, FABMs should be offered to patients during family planning appointments. Broader
dissemination of FABM information and greater efforts to promote their use should be
considered by public health professionals concerned with improving reproductive healthcare for
all women.
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Appendices
Appendix A
Table 1
Summary of demographic variables (n=665)
Demographic Variables

Mean

Age

31.11

8.44

Frequency

Percent

Religious Affiliation
Christian (Protestant)
Christian (Catholic)
Christian (Mormon/LDS)
Christian-Orthodox
Judaism
Islam
Buddhism
Hinduism
Atheist
Agnostic
Spiritual but not religious
Other
None
Relationship/Marital Status
Married
Engaged
Single
Casually Dating
Living with a partner
Divorced
Widowed
Race
White/Caucasian
Black/African American
Hispanic
Native American
Asian
Pacific Islander
Other

SD

143
159
14
24
9
6
6
8
32
50
68
68
78

21.5
23.9
2.1
3.6
1.4
.9
.9
1.2
4.8
7.5
10.2
10.2
11.7

262
39
180
37
119
24
4

39.4
5.9
27.1
5.6
17.9
3.6
.6

487
89
41
5
29
1
13

73.2
13.4
6.2
.8
4.4
.2
2.0
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Table 1 (Cont.)
Summary of demographic variables (n=665)
Demographic Variables
Age
Education
Less than a high school diploma
Some high school/vocational school
Vocational/Technical School
High school graduate or G.E.D
Some college
Associates degree
Bachelors degree
Master’s level graduate
Doctorate level graduate
Professional degree
MD
JD
Other
Insurance Status
Yes
No
I don’t know
Annual Household Income
Less than $15,000
$15,000-$30,000
$30,000-$45,000
$45,000-$60,000
$60,000-$75,000
More than $75,000

Mean
31.11
Frequency

SD
8.44
Percent

14
23
16
146
188
78
155
33
3
4
1
1
3

2.1
3.5
2.4
22.0
28.3
11.7
23.3
5.0
.5
.6
.2
.2
.5

567
88
10

85.3
13.2
1.5

113
123
119
110
71
129

17.0
18.5
17.9
16.5
10.7
19.4
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Table 2
Summary of participant responses to, “When would you consider using a FABM?”

Answer Choice

For health monitoring
For family planning (achieving pregnancy)
For family planning (avoiding pregnancy)
For family planning
(achieving and avoiding pregnancy)
For family planning (achieving pregnancy only)
and health monitoring
For family planning (avoiding pregnancy only)
and health monitoring
For family planning (achieving and avoiding
pregnancy) and health monitoring
I would not use a FABM for monitoring my
health or for family planning
Total

Frequency
107
97
49
62

Percent
16.0
14.5
7.3
9.3

56

8.4

32

4.8

90

13.5

172

25.8

665

100.0
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Table 3
Summary of responses to reproductive health knowledge questions

Knowledge Questions

Answer Choices

Frequency

Percent

Short Cycles (21-25 days)
Regular length cycles (2635 days)
Long cycles (36-48 days)
Cycle Lengths of ONLY
28 days
Other
Short Cycles (21-25
days), Regular length
cycles (26-35 days), Long
cycles (36-48 days)*

157
472

23.6
70.9

75
156

11.2
23.4

33
30

4.9
4.5

1 day
2 days*
3 days*
4 days*
5 days*
7 days*
8 days*
9 days
10 days
11 days
12 days
13 days

3
38
104
279
3
60
168
2
3
2
0
3

.5
5.7
15.6
42.0
.5
9.0
25.3
.3
.5
.3
0
.5

What is considered a
healthy menstrual cycle
length?
(Select all that apply)

How many days is
considered a healthy
length of menses
(bleeding)?
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Table 3 (Cont.)
Summary of responses to reproductive health knowledge questions

Knowledge Questions

Answer Choices

Frequency

Percent

Yes*
No
I don’t know

456
129
80

68.5
19.4
12.0

One*
Two
Three
A woman can ovulate
once a day for more than
three days each cycle
I don’t know

166
54
111
148

25.0
8.1
16.7
22.3

186

28

True
False*

396
269

59.5
40.5

True*
False
I don’t know

532
33
100

80
5
15

Can a female become
pregnant while on her
menses?

How many days in each
Menstrual cycle does a
female ovulate?

True or False: A female is
able to get pregnant at ANY
time in her menstrual cycle?

True or False: Females are
able to identify when they
are fertile by monitoring
external physical signs
such as basal body
temperature, cervical fluid
discharge, or measuring
urinary hormone levels.

Notes: *Correct answer
**Responses were scored "correct" only if the correct answer was selected. All other options
were scored as "incorrect" for the purpose of the analyses
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Table 4
Results of t-test for females interested and not interested in using FABMs for health monitoring
and family planning

Family planning

Health monitoring

Mean
Knowledge
Score
Mean
Knowledge
Score

Interested
n
M SD
386 .69 .20

Not Interested
n
M
SD
279 .75 .23

t
-3.48

p
.00*

285

380

-2.77

.00*

.68

.20

.73

.23

Note: * p < .05.

Table 5
Number of participants who have used or are currently using a birth control pill or other
hormonal contraceptive method as a treatment for a reproductive health problem, such as
irregular cycles, painful periods, bad cramps, heavy periods, other
Answer Choice
Yes
No
Total

Frequency
350
315
665

Percent
52.6
47.4
100.0
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Table 6
Summary of Binary Regression Analysis for Variables Predicting Females’ Interest in Using
FABMs for Health Monitoring or Family Planning
Interest in FABMs (HM)

B SE B
-0.19 .010

β
.981

95% C.I. for β
Lower Upper
.962
1.001

1.833

.302 .184

1.35

.943

1.939

.877

2.298

.194 .238

1.21

.761

1.93

.911

.661

1.254

-.023 .165

.977

.707

1.349

.174

.865

.615

1.216

.270 .175

1.31

.930

1.845

.248

.185

1.28

.892

1.841

-.014 .185

.006

.686

1.417

-.132

.162

.876

.638

1.204

-.197 .164

.821

.596

1.132

Variables

95% C.I. for β
Lower Upper
.966
1.005

B
-.015

SE B
β
.010 .985

Education
(less than
college/some college)

.242

.186

1.27

.885

Insurance Status
(insured/not insured)

.350

.246

1.42

-.094

.163

-.145

Race
(white/not white)
Use of Pill
(used the pill/never
used the pill)

Age

Religious Affiliation
(religiously
affiliated/not
affiliated)
Relationship Status
(committed/not
committed)

Constant Nagelkerke
R Square
N

Interest in FABMs (FP)

.02
665

.028
665

Note: *p < .05.
HM: Interest in FABMs for health monitoring
FP: Interest in FABMs for family planning
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Appendix B

FABM Interest Survey
Start of Block: Demographic Questions
Q107 INFORMED CONSENT STATEMENT
Female Interest in Fertility Awareness Based Methods (FABMs): For Health Monitoring
and Family Planning
IRB#
Amylynn Smith, BS, CFCP University of Arkansas
Heather D. Blunt-Vinti, MPH, PhD
University of Arkansas
The Department of Health, Human Performance, and Recreation at the University of Arkansas
supports the practice of protection for human subjects participating in research. The following
information is provided for you to decide whether you wish to participate in the present study.
You should be aware that participation is completely voluntary and that even if you agree to
participate, you are free to withdraw at any time without penalty. Your relationship with the
investigators will not be affected in any way if you refuse to participate.
We are conducting this study to better understand female knowledge of and interest in fertility
awareness based methods (FABMs) for reproductive health monitoring and family planning.
This will entail your completion of an anonymous online questionnaire. The questionnaire is
expected to take less than 25 minutes to complete. If you participate in this study you will be
one of approximately 3,000 individuals participating in the study. You must be at least 18 years
old to participate.
This survey includes questions about your person knowledge about basic fertility cycle health,
your interest in FABMs for health monitoring and family planning, as well as your satisfaction
with prior family planning methods. If you do not wish to answer a specific question, you may
leave it blank. If at any time you do not wish to continue with this survey, you can exit the study
website.
Although participation may not benefit you directly, we believe that the information obtained
from this study will help us gain a better understanding of what options females prefer for
reproductive health monitoring and family planning options, which may help public health and
education professionals to better design educational programs and research projects in these
areas. In addition, this information may help to encourage the medical community to broaden
the scope of family planning options they provide to patients and how they treat reproductive
health problems. You may also receive compensation from Qualtrics® for your participation.
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All efforts will be made to keep your personal information confidential and the survey will not
collect any identifying information about you (such as your name, birthdate, etc.). We cannot
guarantee absolute confidentiality. Any personal information you provide may be disclosed if
required by law. Your identity will be held in confidence in reports in which the study may be
published and databases in which results may be stored. The researchers have no connection
to any products mentioned in the survey, although aggregate results may be shared with the
company.
Your participation is solicited, although strictly voluntary. If you would like additional information
concerning this study before or after it is completed, please feel free to contact us by phone or
e-mail. At the conclusion of the study, you will have the right to request feedback about the
results.
Starting the survey indicates your willingness to participate in this project and that you are at
least the age of 18. If you have any additional questions about your rights as a research
participant, you may contact either of the following:
The University of Arkansas Research Compliance:
Phone: 479-575-2208
Email: irb@uark.edu
Mail:
Ro Windwalker, CIP
Institutional Review Board Coordinator
Research Compliance
University of Arkansas
109 MLKG Building
Fayetteville, AR 72701-1201
Or
Amylynn Smith, BS, CFCP Principal Investigator
Department of Health, Human Performance and Recreation
University of Arkansas
308-T HPER Building
Fayetteville, AR, 72701
(813) 352-4404
as115@uark.edu
Heather D. Blunt-Vinti, PhD. Principal Investigator
Department of Health, Human Performance and Recreation
University of Arkansas
308-T HPER Building
Fayetteville, AR, 72701
(479) 575-4110
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blunt@uark.edu
Note: if possible we strongly encourage that you complete the survey on a device other than
a mobile phone.
PLEASE CLICK THE >> TO START THE SURVEY

Q104 The purpose of this study, Female Interest in Fertility Awareness Based Methods
(FABMs): For Health Monitoring and Family Planning, is to inquire about your current level of
knowledge in regards to reproductive health and fertility cycle patterns. FABMs are modern
methods of family planning that can be used by females and their partners to monitor their
reproductive health and as a means of achieving or preventing pregnancy.
In addition, we want to know what methods of family planning you have used or are currently
using and if at anytime you discontinued the use of a method and for what reason. We are also
curious if you currently use any of the fertility or period tracking apps available and if so for what
purpose you use them. Lastly, we hope to briefly introduce you to FABMs (if you aren't currently
familiar with them), to learn about your current level of familiarity with FABMs, and your level of
interest in learning to use these methods for various purposes.
This information will enable us to share with the public health and medical community the level
of interest you and women across the nation have in using, or at least learning more about
FABMs.
Thank you for your participation!

Q39 What is your age
▼ 17 and under ... 56 and older

Skip To: End of Survey If What is your age = 17 and under
Skip To: End of Survey If What is your age = 56 and older

Q47 In what state of the United States do you currently live?
▼ Alabama ... Wyoming
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Q40 What ethnicity/race do you most identify with?
▼ Asian ... Other

Q41 What is your sex?

o Male
o Female
o Other (please specify): ________________________________________________
Skip To: End of Survey If What is your sex? = Male
Skip To: End of Survey If What is your sex?(Other (please specify):) Is Not Empty

Q48 What is your current marital/relationship status?
▼ Casually Dating ... Widowed

Q44 What is your religion (if any)?
▼ Agnostic ... Other

Q43 What is the highest level of education you have completed?
▼ Less than a high school diploma ... Other
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Q45 Which of the following categories is closest to the total income of your household per year?
▼ Less than $15,000 ... More than $75,000

Q46 Do you currently have health insurance?

o Yes
o No
o I don't know
Q52 How many times have you been pregnant?
▼ 0 ... more than 10

Q54 How many pregnancies have you had that resulted in the birth of a living child? (total
number of children born alive)
▼ 0 ... More than 10

Q2.3 Please check below any of the conditions or surgeries that you have had (check all that
apply):

▢
▢

Menopause (change of life)

Hysterectomy (uterus removed)

Skip To: End of Survey If Please check below any of the conditions or surgeries that you have had (check
all that apply): = Menopause (change of life)
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Skip To: End of Survey If Please check below any of the conditions or surgeries that you have had (check
all that apply): = Hysterectomy (uterus removed)

End of Block: Demographic Questions
Start of Block: Fertility Health Questions
Q53
The following questions are for the purpose of understanding your current knowledge about the
female menstrual cycle, and your experience with medical providers treating menstrual cycle
problems.
For the purpose of this survey we define menstrual cycle, menses, and ovulation as:
menstrual cycle: All of the days from the start of one period until the day before your
next period
menses: The days of your cycle when you are bleeding ovulation: When the
egg or ovum is released

Q1.2 What is considered a healthy menstrual cycle length? (Select all that apply)

▢
▢
▢
▢
▢

Short Cycles (21-25 days)

Regular Length Cycles (26-35 days)

Long Cycles (36-48 days)

Cycle lengths of ONLY 28 days

Other

Q60 How many days is considered a healthy length of menses (bleeding)?
▼ 1 ... 12
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Q91 Can a female become pregnant while on her menses?

o Yes
o No
o I don't know
Q54 How many DAYS in each menstrual cycle does a female ovulate?

o One
o Two
o Three
o A woman can ovulate once a day for more than three days each cycle
o I don't know
Q51 True or False: It is NOT necessary for a female to ovulate regularly (approximately once a
month) in order to be considered healthy as long as she is regularly bleeding.

o True
o False
o I don't know
Q59 True or False: A female is able to get pregnant at ANY time in her menstrual cycle?

o True
o False
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Q50 True or False:
Females are able to identify when they are fertile by monitoring external physical signs such as:
basal body temperature, cervical fluid discharge, or measuring urinary hormone levels.

o True
o False
o I don't know
Q70 This question is to make sure you are truly reading and answering the questions. If you are
reading and answering questions please choose, "I am reading and answering questions," as
your answer choice.

o I am not really reading
o I don't care
o I am reading and answering questions
Skip To: End of Survey If This question is to make sure you are truly reading and answering the
questions. If you are readi... = I am not really reading
Skip To: End of Survey If This question is to make sure you are truly reading and answering the
questions. If you are readi... = I don't care
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Q92 Where did you learn about what a healthy menstrual cycle is? Select all that apply.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Father

Mother

Sibiling

Other family member

A friend

An FABM educator

Sex education Class (school-based program)

General Health/Science Class

A partner

A medical website

Social media

Women's health care professional

Primary care physician

Product labels

Smart phone apps
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▢
▢
▢

Community health class

Planned Parenthood

Other

Q111 Have you ever used or are you currently using a birth control pill or other hormonal
contraceptive method as a treatment for a reproductive health problem such as:
Irregular cycles
Painful periods
Bad cramps Heavy periods
Other

o Yes
o No
Display This Question:
If Have you ever used or are you currently using a birth control pill or other hormonal contraceptiv... =
Yes

Q112 If you have used, or are currently using, a birth control pill or other hormonal contraceptive
as a treatment for a reproductive health problem, who prescribed the treatment?

o Medical Professional
o Self-Prescribed
o Parent/Family Member
o Other

63

Display This Question:
If If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... =
Medical Professional
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... =
Self-Prescribed
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... =
Parent/Family Member
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... =
Other

Q115 Select the reason you FIRST started using the birth control pill or other hormonal
contraceptives to treat a reproductive health problem?

Choose ALL that apply.

▢
▢
▢
▢
▢
▢

Irregular Cycles

Too long in-between periods

Painful Periods

Heavy Periods

Severe Cramping

Other
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Display This Question:
If Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Irregular Cycles
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Too long in-between periods
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Painful Periods
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Heavy Periods
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Severe Cramping
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives...
= Other

Q113
At what age did you FIRST start taking the birth control pill or other hormonal contraceptives as
a treatment for your reproductive health problem(s)?
▼ younger than 8 ... after 50

Q89 The behaviors listed below are ways you can monitor your menstrual cycle health, and
times of fertility and infertility. Please mark your willingness to perform the following behaviors to
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prevent pregnancy without the use of hormonal supplements, devices, or other methods of
artificial birth control.
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Keeping track of
my period
lengths
Taking your
temperature first
thing every
morning
Wiping with toilet
tissue before
and after EVERY
bathroom visit to
feel for a
sensation of
slippery/lubricati
on
Wiping with toilet
tissue before
and after EVERY
bathroom visit
looking for
cervical fluid on
a tissue
Wiping with toilet
before and after
EVERY
bathroom visit
and finger
testing (trying to
stretch) cervical
fluid found on
your tissue
Peeing on a stick
every morning
and inserting it
into a monitor
that tells you
how likely you
are to get
pregnant that
day if you have
sex

I am NOT willing

I might be willing
if I knew more

I am willing

I am already
doing this

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

67

Recording the
most fertile
observation you
saw during the
day in a chart or
on an app before
going to bed
each night

o

o

o

o

Q76 Please check below ALL statements that apply to you.

▢
▢
▢
▢
▢

I have had my tubes tied (a surgical tubal ligation to prevent pregnancy)

I have had both of my ovaries removed (not just one)

I have had a surgery that has made me unable to get pregnant for the rest of my life

I have a condition that makes me unable to get pregnant for the rest of my life.

None of the above apply to me

Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had both of my
ovaries removed (not just one)
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had a surgery
that has made me unable to get pregnant for the rest of my life
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have a condition that
makes me unable to get pregnant for the rest of my life.
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had my tubes
tied (a surgical tubal ligation to prevent pregnancy)
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Q38 With whom do you intend to or with whom do you engage in sexual activity?

o Men only
o Women only
o Both men and women
o I do not intend to EVER engage in sexual activity
Skip To: End of Survey If With whom do you intend to or with whom do you engage in sexual activity? =
Women only
Skip To: End of Survey If With whom do you intend to or with whom do you engage in sexual activity? = I
do not intend to EVER engage in sexual activity

End of Block: Fertility Health Questions
Start of Block: Fertility Monitoring Question
Q105
The remaining questions will ask you about the following:
1. What methods of family planning you have used or are currently using
2. If at anytime you discontinued the use of a method and for what reason
3. Are you currently using any of the fertility or period tracking apps available and if so for what
purpose you use them.
4. You will be briefly introduced to fertility awareness based methods (FABMs), asked about
your current level of familiarity with FABMs, and your level of interest in learning to use these
methods for various purposes.
For the purpose of this survey we define menstrual cycle, menses, and ovulation as:
menstrual cycle: as all of the days from the start of one period until the day before your
next period
menses: the days of your cycle when you are bleeding
ovulation: when the
egg or ovum is released
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Q67 What characteristics are important to you when considering a method to use for family
planning? (check ALL that apply)

▢
▢
▢
▢
▢
▢

Reliability (e.g., effectiveness)

Ease of use

Acceptability of method to a partner

Potential side effects

Cost

Other (please list): ________________________________________________
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Q1.13 Which method(s) of family planning do you currently use? Check all that apply.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Condom

Withdrawl ("pulling out")

Birth control pill

Birth control patch

Vaginal ring (e.g., NuvaRing)

The shot (Depo Provera)

Spermicide foam/jelly/cream/film

Hormonal IUD (e.g., Mirena, Skyla)

Non-hormonal IUD (e.g., Paragard)

Hormonal implant (e.g., Implanon, Nexplanon)

Diaphragm

Female tubal sterilization (e.g., tubes tied)

In Vitro Fertilization (IVF)

Emergency contraception (e.g., "Plan B")

Calendar Rhythm
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▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Billings Ovulation Method (cervical mucus method)

Creighton Model Method (cervical mucus method)

Sympto-Thermal Method

Sympto-Hormonal Method

Lacational Amenhorea Method

Standard Days Method

Two Day Method

Other (please specify): ________________________________________________

I do not currently use a method of family planning

None of these methods
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Q1.14 Which of the following have you ever used but discontinued using? Please indicate all
that apply, and provide a reason for discontinuation for each method that you have previously
used in the associated text box. Please provide as detailed of description as you are able to.
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How long did you use this
method?

Reason for discontinuation

Condom
Withdrawl ("pulling out");
reason for discontinuation:
Birth control pill; reason for
discontinuation:
Birth control patch; reason for
discontinuation:
Vaginal ring (e.g., NuvaRing);
reason for discontinuation:
The shot (Depo Provera);
reason for discontinuation:
Spermicide
foam/jelly/cream/film; reason
for discontinuation:
Hormonal IUD (e.g., Mirena,
Skyla); reason for
discontinuation:
Non-hormonal IUD (e.g.,
Paragard); reason for
discontinuation:
Hormonal implant (e.g.,
Implanon, Nexplanon); reason
for discontinuation:
Diaphragm; reason for
discontinuation:
Emergency contraception
(e.g., "Plan B"); reason for
discontinuation:
Female tubal sterilization
(e.g., tubes tied)
Male sterilization (e.g.,
vasectomy)
Calendar Rhythm
Billings Ovulation Method
(cervical mucus method)
Creighton Model (cervical
mucus method)
Sympto-Thermal Method
Sympto-Hormonal: Marquette
Method
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Lacational Amenhorea
Method
Standard Days Method
Two Day Method
None of these methods
Other (please specify):

Q97 Do you use a period tracking OR fertility tracking app?

o Yes
o No
Skip To: Q100 If Do you use a period tracking OR fertility tracking app? = No

Display This Question:
If Do you use a period tracking OR fertility tracking app? = Yes

Q98 Which app or apps dd you use?
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Display This Question:
If If Which app or apps dd you use? Text Response Is Displayed
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Q99 What is your purpose(s) for using a period tracking or fertility tracking app? Check all that
apply.

▢
▢
▢
▢
▢
▢

To prevent pregnancy

To achieve a pregnancy

To monitor timing of menses

To monitor cycle health

To predict the start of my menses (my period)

Other ________________________________________________

Display This Question:
If What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
To prevent pregnancy
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
To achieve a pregnancy
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
To monitor timing of menses
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
To monitor cycle health
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
To predict the start of my menses (my period)
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. =
Other
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Q48 What is your commitment to the period tracking or fertility tracking app?

o Downloaded app(s) but do not use the regularly
o Downloaded app(s) and use it regularly for period tracking
o Downloaded app(s) and use it regularly for fertility tracking
o Downloaded app(s) and use it regularly for period and fertility tracking
o Other ________________________________________________
Q100 Have you ever made a decision about whether to have intercourse (or whether to use a
condom or withdrawal method), based on whether you thought it was a fertile day or not?

o Yes
o No
o I do not recall
Skip To: Q51 If Have you ever made a decision about whether to have intercourse (or whether to use a
condom or wi... = No
Skip To: Q51 If Have you ever made a decision about whether to have intercourse (or whether to use a
condom or wi... = I do not recall

Display This Question:
If Have you ever made a decision about whether to have intercourse (or whether to use a condom or
wi... = Yes

Q101 If yes, was that decision about whether to have intercourse (or whether to use a condom
or withdrawal method) based on information you gained from your fertility tracking or period
tracking app(s)?

o Yes
o No
Q51 Natural or fertility awareness based methods (FABMs) are modern methods of family
planning that can be used by females to monitor their reproductive health and by females and
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their partners to achieve or prevent pregnancy.
FABMs are based on the external
observation and tracking of various biological markers (for example: cervical fluid discharge,
basal body temperature, monitoring of urinary hormones). FABMs can be used by women with
REGULAR and IRREGULAR cycle patterns FABMs use NO chemicals, NO internal devices,
and have ZERO medical side effects.
When couples use modern FABMs correctly, they are 95-99.5% effective at preventing
pregnancy. With typical use, which includes women or couples that may make mistakes in using
the methods, the effectiveness rates for avoiding pregnancy is 78-98%.
In addition, in 2015 the American College of Obstetricians and Gynecologists, in collaboration
with the American Academy of Pediatrics, encourage ALL adolescent females to monitor their
menstrual cycles (timing of menses, patterns of cycles, and associated symptoms- pain,
discomfort, etc...). Read here for more information.
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Q66 Please check below ALL Fertility Awareness Based Methods (FABMs) that you are at all
FAMILIAR with even if you have never used an FABM.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Calendar rhythm

Creighton Model Method (Cervical Fluid)

Billings Ovulation Method (Cervical Fluid)

Sympto-thermal

Sympto-Hormonal (Marquette Method)

Lacational Amenhorea Method

Standard Days Method

Two Day Method

Family of the Americas (Cervical Fluid Method)

FEMM (Fertility Education and Medical Management)

Justisse Method

Ecological Breastfeeding

Taking Charge of Your Fertility

I have never heard of fertility awareness based methods (FABMs)

Other (please specify): ________________________________________________
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Q1.12 Please check below ALL Fertility Awareness Based Methods (FABMs) that you have
EVER used TO MONITOR YOUR REPRODUCTIVE/MENSTRUAL CYCLE HEALTH ONLY.
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***This does NOT include using FABMs for the purposes of trying to achieve or avoid
pregnancy.***

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Calendar rhythm

Creighton Model Method (Cervical Fluid Method)

Billings Ovulation Method (Cervical Fluid Method)

Sympto-thermal

Sympto-Hormonal (Marquette Method)

Lacational Amenhorea Method

Standard Days Method

Two Day Method

Family of the Americas (Cervical Fluid Method)

FEMM (Fertility Education and Medical Management)

Justisse Method

Ecological Breastfeeding

Taking Charge of Your Fertility

I have never used an FABM to monitor or treat my reproductive health

Other (please specify) ________________________________________________
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Display This Question:
If Please check below ALL Fertility Awareness Based Methods (FABMs) that you have EVER
used TO MON... = Calendar rhythm

Q110 You marked that you have used the Calendar Rhythm Method to monitor your
reproductive/menstrual cycle health.

Please explain what the Calendar Rhythm Method is.
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Q2.14 When would you consider using an FABM?

o For monitoring my health
o For family planning (achieving pregnancy only)
o For family planning (avoiding pregnancy only)
o For family planning (achieving and avoiding pregnancy)
o For family planning (achieving pregnancy only) and health monitoring
o For family planning (avoiding pregnancy only) and health monitoring
o For family planning (achieving and avoiding pregnancy) and health monitoring
o I would not use FABM for monitoring my health or for family planning, even if I was confident
in reliability, it was easy to learn and acceptable to my partner
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Q71 This question is to make sure you are truly reading and answering the questions. If you are
reading and answering questions please choose, "I am reading and answering questions," as
your answer choice.

o I am not really reading
o I don't care
o I am reading and answering questions
Skip To: End of Survey If This question is to make sure you are truly reading and answering the
questions. If you are readi... = I am not really reading
Skip To: End of Survey If This question is to make sure you are truly reading and answering the
questions. If you are readi... = I don't care
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Q2.12 Please check below ALL fertility awareness based methods (FABMs) that you and your
partner have EVER used TO TRY TO PREVENT PREGNANCY.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Calendar rhythm

Creighton Model Method (Cervical Fluid Method)

Billings Ovulation Method (Cervical Fluid Method)

Sympto-thermal

Sympto-Hormonal (Marquette Fertility Monitor)

Lacational Amenhorea Method

Standard Days Method

Two Day Method

Family of the Americas (Cervical Fluid Method)

FEMM (Fertility Education and Medical Management)

Justisse Method

Ecological breastfeeding

Taking Charge of Your Fertility

I have never used an FABM to prevent a pregnancy

Other please specify): ________________________________________________
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Q102 Please check below ALL fertility awareness based methods (FABMs) that you and your
partner have EVER used TO TRY TO GET PREGNANT.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Calendar rhythm

Creighton Model Method (Cervical Fluid Method)

Billings Ovulation Method (Cervical Fluid Method)

Sympto-thermal

Sympto-Hormonal (Marquette Fertility Monitor)

Lacational Amenhorea Method

Standard Days Method

Two Day Method

Family of the Americas (Cervical Fluid Method)

FEMM (Fertility Education and Medical Management

Justisse Method

Ecological breastfeeding

Taking Charge of Your Fertility

I have never used an FABM to achieve a pregnancy

Other ________________________________________________
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Q2.17 Please mark other females that you think might be interested in learning more about
FABMs for health monitoring.

▢
▢
▢
▢
▢
▢
▢

Mother

Sister

Daughter

Other family member

Friend

Other

I do not think females are interested in learning or using FABMs
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Q103 Please mark other females that you think might be interested in learning more about
FABMs for family planning. Mark all that apply.

▢
▢
▢
▢
▢
▢
▢

Mother

Sister

Daughter

Other family member

Friend

Other

I do not think females are interested in learning or using FABMs

Q55 You can find more information about fertility awareness based methods (FABMs) by
visiting the following websites:
Fertility Awareness Based Methods (FABMs):
Marquette Method (Sympto-hormonal)
Lactational Amenorrhea Method
Standard Days Method
Two-Day Method
Sympto-thermal Method**
Creighton Model Method
Billings Ovulation Method
Justisse Method
***There are multiple methods that teach using the Sympto-thermal approach. This is linked to
one organization of educators. Below in 'Other Resources' you will find another, FEMM Health.
On the FACTS page you can find even more resources.
Other Resoucres:
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FEMM Health
Fertility Appreciation Collaborative to Teach the Science (FACTS)
End of Block: Fertility Monitoring Question
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Appendix C

89

